Dark

LMAT
LeMaitre Vascular, Inc.
stock NASDAQ

At Close

Jul 10, 2026 3:59:57 PM EDT

102.83USD+0.420%(+0.43)311,458

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-102.40)0

After-hours

Jul 9, 2026 4:00:30 PM EDT

102.40USD-0.029%(-0.03)0

OverviewOptionsHistoricalExchangesShortsNews

Dec 30, 2021

11:24AM EST LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 24th Annual Needham Virtual Growth Conference on Friday, January 14, 2022, at 3:30 PM. GlobeNewswire Inc

Nov 2, 2021

01:52PM EDT LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today that management will be participating in three upcoming virtual investor conferences. GlobeNewswire Inc

Oct 29, 2021

08:00AM EDT The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs Benzinga

Oct 28, 2021

04:45PM EDT Recap: LeMaitre Vascular Q3 Earnings Benzinga

04:29PM EDT LeMaitre Vascular Sees Q4 EPS $0.29-$0.34 Vs. $0.34 Est., Sales $39M-$41M Vs. $40.18M Est.; FY21 EPS $1.26-$1.31 Vs. $1.35 Est., Sales $153.9M-$155.9M Vs. $155.8M Est. Benzinga

04:27PM EDT LeMaitre Vascular Q3 EPS $0.30 Misses $0.32 Estimate, Sales $38.37M Miss $39.05M Estimate Benzinga

08:26AM EDT The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug Benzinga

04:08AM EDT Earnings Scheduled For October 28, 2021 Benzinga

Oct 24, 2021

11:45AM EDT The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More Benzinga

Oct 14, 2021

04:10PM EDT LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today that it will release its third quarter 2021 financial results onThursday, October 28, 2021, after the market close. The company has scheduled a conference call for5:00 PM ETthe same day to discuss the results, business highlights, and company outlook. GlobeNewswire Inc

Sep 16, 2021

10:07AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021 Benzinga

08:08AM EDT Jefferies Initiates Coverage On LeMaitre Vascular with Buy Rating, Announces Price Target of $70 Benzinga

Sep 1, 2021

04:47PM EDT UPDATE: LeMaitre Vascular Says Also Entered Into An Amendment To A Transition Services Agreement With Admedus, Says Amendment Extends Term Of Agreement By 9 Months To July 11, 2023 Benzinga

04:46PM EDT UPDATE: LeMaitre Vascular Says Costs Of Obtaining CE Mark Approvals Will Also Be Assumed By Co., Says Costs Will Be Deducted From $2M Earn-Out Associated With CE Mark Approvals Benzinga

04:44PM EDT UPDATE: LeMaitre Vascular Says Will Assume Responsibility For Filing For Regulatory Approvals For Products Under European Union Medical Device Regulation Benzinga

04:44PM EDT LeMaitre Vascular Says On Aug. 28, Amended Agreement Co. Previously Entered Into, On Oct. 11, 2019 With Admedus, Certain Of Units Benzinga

03:21PM EDT LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four virtual investor conferences in September. GlobeNewswire Inc

Aug 10, 2021

02:42PM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Aug 6, 2021

11:07AM EDT LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August. GlobeNewswire Inc

Aug 3, 2021

09:26AM EDT Roth Capital Maintains Neutral on LeMaitre Vascular, Raises Price Target to $58 Benzinga

Jul 29, 2021

04:46PM EDT LeMaitre Sees FY21 EPS $1.30-$1.40, Sales $154.1M-$158.1M Benzinga

04:45PM EDT LeMaitre Sees Q3 EPS $0.30-$0.35, Sales $38.3M-$40.3M; Q4 EPS $0.33-$0.38, Sales $39.3M-$41.3M Benzinga

04:44PM EDT LeMaitre Vascular Q2 EPS $0.40 Beats $0.31 Estimate, Sales $40.70M Beat $37.97M Estimate Benzinga

04:23AM EDT Earnings Scheduled For July 29, 2021 Benzinga

Jul 15, 2021

05:01PM EDT LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2021 financial results on Thursday, July 29, 2021, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. GlobeNewswire Inc

Jul 14, 2021

07:48AM EDT The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues Benzinga

06:57AM EDT LeMaitre Vascular Sees Better Than Expected Q2 Sales, Raises $55M Via Equity At 9% Discount Benzinga

Jul 13, 2021

11:04PM EDT LeMaitre Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc

04:04PM EDT LeMaitre Vascular Announces Proposed Public Offering of Common Stock; No Terms Disclosed Benzinga

04:04PM EDT LeMaitre Vascular Announces Proposed Public Offering of Common Stock GlobeNewswire Inc

04:03PM EDT LeMaitre Vascular Sees Q2 Prelim Sales $40.7M Vs. $37.97M Est. Benzinga

04:03PM EDT LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced preliminary unaudited results for the quarter ended June 30, 2021. GlobeNewswire Inc

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

Jun 18, 2021

07:46AM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Jun 17, 2021

08:33AM EDT The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme Benzinga

Jun 16, 2021

08:20AM EDT The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO Benzinga

Jun 15, 2021

08:07AM EDT The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda Benzinga

Jun 9, 2021

09:29AM EDT LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today thatDavid Roberts, President, will present attheGoldman Sachs 42nd Annual Virtual Global Healthcare Conference onThursday, June 10, 2021, at5:30 PM ET. GlobeNewswire Inc

May 25, 2021

01:48PM EDT LeMaitre Highlights Received 5 CE Marks Under European Medica Devices Directive Benzinga

01:47PM EDT LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it received CE marks under the European Medical Devices Directive (93/42/EC as amended by 2007/47/EC) for the following five products. Marks for the five products had previously lapsed due to a change in notified bodies. GlobeNewswire Inc

May 20, 2021

05:53PM EDT LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today thatJJ Pellegrino, Chief Financial Officer, will present atthe Jefferies Virtual Healthcare ConferenceonFriday, June 4, 2021, at1:30 PM EDT. GlobeNewswire Inc

May 17, 2021

10:14AM EDT Analyzing LeMaitre Vascular's Ex-Dividend Date Benzinga

May 4, 2021

08:33AM EDT Roth Capital Maintains Neutral on LeMaitre Vascular, Raises Price Target to $55 Benzinga

Apr 29, 2021

05:15PM EDT Recap: LeMaitre Vascular Q1 Earnings Benzinga

04:34PM EDT LeMaitre Sees Q2 Adj. EPS $0.28-$0.36 vs $0.28 Est., Sales $37M-$40M vs $35.88M Est. Benzinga

04:33PM EDT LeMaitre Vascular Q1 EPS $0.28 Beats $0.27 Estimate, Sales $35.90M Beat $35.20M Estimate Benzinga

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

04:10AM EDT Earnings Scheduled For April 29, 2021 Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 14, 2021

04:54PM EDT LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today that it will release its first quarter 2021 financial results onThursday, April 29, 2021, after the market close. The company has scheduled a conference call for5:00 PM EDTthe same day to discuss the results, business highlights, and company outlook. GlobeNewswire Inc

Apr 5, 2021

12:59PM EDT LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today thatJJ Pellegrino, Chief Financial Officer, will present atthe 20th Annual Needham Virtual Healthcare Conference onMonday, April 12, 2021, at9:30 AM EDT. GlobeNewswire Inc

Mar 5, 2021

10:11AM EST Analyzing LeMaitre Vascular's Ex-Dividend Date Benzinga

Feb 25, 2021

05:33PM EST LeMaitre Vascular Q4 EPS $0.34 Beats $0.29 Estimate, Sales $37.55M Beat $35.58M Estimate Benzinga

05:33PM EST LeMaitre Vascular Sees Q1 EPS $0.24-$0.31 Vs. $0.23 Est., Sales $33.8M-$36.8M Vs. $34.81M Est. Benzinga

05:15PM EST Recap: LeMaitre Vascular Q4 Earnings Benzinga

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 24, 2021

10:27AM EST Earnings Preview for LeMaitre Vascular Benzinga

Feb 16, 2021

04:40PM EST LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today that it is participating in four upcoming investor conferences. GlobeNewswire Inc

Feb 12, 2021

10:06AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 12, 2021 Benzinga

05:19AM EST KeyBanc Initiates Coverage On LeMaitre Vascular with Sector Weight Rating Benzinga

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

Jan 27, 2021

01:07PM EST LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today that it will release its fourth quarter 2020 financial results onThursday, February 25, 2021, after the market close. The company has scheduled a conference call for5:00 PM ETthe same day to discuss the results, business highlights, and company outlook. GlobeNewswire Inc

10:07AM EST Stocks That Hit 52-Week Highs On Wednesday Benzinga

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 8, 2021

07:25AM EST The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga

Jan 6, 2021

07:31AM EST The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping Benzinga

Dec 29, 2020

06:04PM EST LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today that it is participating in two investor conferences in January. GlobeNewswire Inc

Nov 24, 2020

08:13AM EST The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia Benzinga

Nov 18, 2020

07:30AM EST The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted Benzinga

Nov 17, 2020

10:17AM EST Understanding LeMaitre Vascular's Ex-Dividend Date Benzinga

Nov 11, 2020

04:35PM EST LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 12:25 PM ET. GlobeNewswire Inc

Nov 4, 2020

09:51AM EST LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today that it is participating in two investor conferences in November. GlobeNewswire Inc

Oct 30, 2020

10:05AM EDT Roth Capital Maintains Neutral on LeMaitre Vascular, Raises Price Target to $36 Benzinga

Oct 29, 2020

05:27PM EDT LeMaitre Vascular: Q3 Earnings Insights Benzinga

04:49PM EDT LeMaitre Vascular Sees Q4 Sales Of $34M-$38M Vs $33.46M Estimates, EPS $0.25-$0.35 Vs $0.22 Estimates; FY20 Sales $125.8M-$129.8M vs $120.47M Estimates Benzinga

04:47PM EDT LeMaitre Vascular Q3 EPS $0.37 Beats $0.19 Estimate, Sales $36.42M Beat $31.62M Estimate Benzinga

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

04:08AM EDT Earnings Scheduled For October 29, 2020 Benzinga

Oct 9, 2020

06:18PM EDT LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today that it will release its third quarter 2020 financial results onThursday, October 29, 2020, after the market close. The company has scheduled a conference call for5:00 PM EDTthe same day to discuss the results, business highlights, and company outlook. GlobeNewswire Inc

Aug 31, 2020

03:33PM EDT LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in three investor conferences in September. GlobeNewswire Inc

Jul 29, 2020

12:12PM EDT LeMaitre Vascular, Inc.(Nasdaq:LMAT) announced today that it is participating in two investor conferencesin August. GlobeNewswire Inc

Jul 24, 2020

11:14AM EDT Stifel Maintains Hold on LeMaitre Vascular, Raises Price Target to $30 Benzinga

10:14AM EDT Canaccord Genuity Maintains Hold on LeMaitre Vascular, Raises Price Target to $30 Benzinga

Jul 23, 2020

05:14PM EDT Recap: LeMaitre Vascular Q2 Earnings Benzinga

04:33PM EDT LeMaitre Vascular Sees Q3 EPS $0.17-$0.26 May Not Compare To $0.08 Est., Sales $30.5M-$34.5M vs $20.94M Est. Benzinga

04:25PM EDT LeMaitre Vascular Q2 EPS $0.17 Beats $0.01 Estimate, Sales $24.90M Beat $17.12M Estimate Benzinga

04:30AM EDT Earnings Scheduled For July 23, 2020 Benzinga